Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 22Recruiting 7Unknown 3Withdrawn 2Terminated 2Not yet recruiting 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Oropharyngeal Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Absorptiometry, Photon × Clear all
NCT00996749 2018-07-03

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

Wake Forest University Health Sciences

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02628912 2018-01-04

Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers

Memorial Sloan Kettering Cancer Center

Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡